Erwin Schleicher

16.7k total citations · 4 hit papers
203 papers, 12.0k citations indexed

About

Erwin Schleicher is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Clinical Biochemistry. According to data from OpenAlex, Erwin Schleicher has authored 203 papers receiving a total of 12.0k indexed citations (citations by other indexed papers that have themselves been cited), including 91 papers in Molecular Biology, 59 papers in Endocrinology, Diabetes and Metabolism and 40 papers in Clinical Biochemistry. Recurrent topics in Erwin Schleicher's work include Metabolism, Diabetes, and Cancer (41 papers), Advanced Glycation End Products research (32 papers) and Diabetes and associated disorders (26 papers). Erwin Schleicher is often cited by papers focused on Metabolism, Diabetes, and Cancer (41 papers), Advanced Glycation End Products research (32 papers) and Diabetes and associated disorders (26 papers). Erwin Schleicher collaborates with scholars based in Germany, United States and Italy. Erwin Schleicher's co-authors include Cora Weigert, Michael Nerlich, Rainer Lehmann, Franz Ledl, Hans‐Ulrich Häring, Andreas Fritsche, Ernst Wagner, Norbert Stefan, Hans Häring and Katrin Brodbeck and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Erwin Schleicher

198 papers receiving 11.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging.

1997 603 citations Erwin Schleicher, Ernst Wagner et al. Journal of Clinical Investigation profile →
New Aspects of the Maillard Reaction in Foods and in the Human Body

1990 582 citations Erwin Schleicher et al. profile →
Definition, Classification and Diagnosis of Diabetes Mellitus

2019 377 citations Astrid Petersmann, Dirk Müller‐Wieland et al. Experimental and Clinical Endocrinology & Diabetes profile →
The impact of insulin resistance on the kidney and vasculature

2016 317 citations Erwin Schleicher, Cora Weigert et al. profile →

Peers

Countries citing papers authored by Erwin Schleicher

Since Specialization

Citations

This map shows the geographic impact of Erwin Schleicher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erwin Schleicher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erwin Schleicher more than expected).

Fields of papers citing papers by Erwin Schleicher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erwin Schleicher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erwin Schleicher. The network helps show where Erwin Schleicher may publish in the future.

Co-authorship network of co-authors of Erwin Schleicher

This figure shows the co-authorship network connecting the top 25 collaborators of Erwin Schleicher. A scholar is included among the top collaborators of Erwin Schleicher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erwin Schleicher. Erwin Schleicher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Correction: Definition, Classification, Diagnosis and Differential Diagnosis of Diabetes Mellitus: Update 2023 2024 ·Experimental and Clinical Endocrinology & Diabetes ·Stefan Pleus, (unknown), Rüdiger Landgraf, Lutz Heinemann, Christoph Werner, Dirk Müller‐Wieland, Anette‐Gabriele Ziegler, Ulrich Müller, Guido Freckmann, Helmut Kleinwechter, Erwin Schleicher, Matthias Nauck, Astrid Petersmann	1
2	Association of transketolase polymorphisms with diabetic polyneuropathy in the general population: The KORA F4 study 2024 ·Diabetes/Metabolism Research and Reviews ·Dan Ziegler, Barbara Thorand, Alexander Strom, Gidon J. Bönhof, (unknown), Erwin Schleicher, Wolfgang Rathmann, Christian Herder, Haïfa Maalmi, Christian Gieger, Margit Heier, Christa Meisinger, Michael Roden, Annette Peters, Harald Grallert	0
3	Extracellular Matrix Expression in Human Pancreatic Fat Cells of Patients with Normal Glucose Regulation, Prediabetes and Type 2 Diabetes 2023 ·International Journal of Molecular Sciences ·Dorothea Siegel‐Axel, (unknown), Felicia Gerst, Falko Fend, Róbert Wágner, Martin Heni, Alfred Königsrainer, Hans‐Ulrich Häring, Andreas Fritsche, Erwin Schleicher, Andreas L. Birkenfeld, Norbert Stefan	1
4	Clinical Pathobiochemistry of Vitamin B12 Deficiency: Improving Our Understanding by Exploring Novel Mechanisms with a Focus on Diabetic Neuropathy 2023 ·Nutrients ·Erwin Schleicher, Triantafyllos Didangelos, Evangelia Kotzakioulafi, Alexander Čegan, Andreas Peter, Kοnstantinos Kantartzis	13
5	Combined choline and DHA supplementation: a randomized controlled trial 2019 ·European Journal of Nutrition ·Wolfgang Bernhard, (unknown), Christoph Maas, (unknown), (unknown), (unknown), (unknown), Erwin Schleicher, Christian F. Poets, Axel R. Franz	34
6	ALCAM a novel biomarker in patients with type 2 diabetes mellitus complicated with diabetic nephropathy 2017 ·Journal of Diabetes and its Complications ·Alba Sulaj, Stefan Kopf, Elisabeth Gröne, Hermann-Josef Gröne, Sigrid Hoffmann, Erwin Schleicher, Hans-Ulrich Häring, Vedat Schwenger, Stephan Herzig, Thomas Fleming, Peter P. Nawroth, (unknown)	14
7	Comparable Autoantibody Serum Levels against Amyloid- and Inflammation-Associated Proteins in Parkinson’s Disease Patients and Controls 2014 ·PLoS ONE ·Walter Maetzler, Anja Apel, Markus Langkamp, Christian Deuschle, (unknown), (unknown), Claudia Schulte, Erwin Schleicher, Thomas Gasser, Daniela Berg	34
8	In vivo markers of Parkinson’s disease and dementia with Lewy bodies: current value of the 5G4 α-synuclein antibody 2014 ·Acta Neuropathologica ·Walter Maetzler, Andrea Pilotto, Anja Apel, Christian Deuschle, (unknown), Sebastian Heinzel, Inga Liepelt‐Scarfone, Claudia Schulte, (unknown), Erwin Schleicher, Oliver C. Rothfuss, Anja Schneider, Richard Dodel, Thomas Gasser, Daniela Berg	7
9	Identification of the Amino Acids 300–600 of IRS-2 as 14-3-3 Binding Region with the Importance of IGF-1/Insulin-Regulated Phosphorylation of Ser-573 2012 ·PLoS ONE ·(unknown), Rachel Toth, Nick Morrice, David G. Campbell, Carol MacKintosh, Rainer Lehmann, Hans-Ulrich Haering, Erwin Schleicher, Cora Weigert	11
10	The Maillard reaction : recent advances in food and biomedical sciences 2008 ·Erwin Schleicher, Veronika Somoza, Peter Schieberle	8
11	The −913 G/A Glutamine:Fructose-6-Phosphate Aminotransferase Gene Polymorphism Is Associated with Measures of Obesity and Intramyocellular Lipid Content in Nondiabetic Subjects 2005 ·The Journal of Clinical Endocrinology & Metabolism ·Cora Weigert, Claus Thamer, Katrin Brodbeck, (unknown), Fausto Machicao, Jürgen Machann, Fritz Schick, Michael Stümvoll, Andreas Fritsche, Hans Häring, Erwin Schleicher	11
12	Upstream Stimulatory Factor (USF) Proteins Induce Human TGF-β1 Gene Activation via the Glucose-response Element–1013/–1002 in Mesangial Cells 2004 ·Journal of Biological Chemistry ·Cora Weigert, Katrin Brodbeck, Michèle Sawadogo, Hans Häring, Erwin Schleicher	61
13	Glucose oversupply increases Δ9-desaturase expression and its metabolites in rat skeletal muscle 2003 ·Diabetologia ·(unknown), Hans Günther Wahl, (unknown), (unknown), Michael Haap, Fausto Machicao, H. P. T. Ammon, W. Renn, Erwin Schleicher, Hans‐Ulrich Häring	24
14	Alkaline liquid chromatography/electrospray ionization skimmer collision‐induced dissociation mass spectrometry for phosphopeptide screening 2001 ·Rapid Communications in Mass Spectrometry ·Alexander Beck, Martin Deeg, Klaus Moeschel, (unknown), Erwin Schleicher, Wolfgang Voelter, Hans Häring, Rainer Lehmann	25
15	Role of the hexosamine biosynthetic pathway in diabetic nephropathy 2000 ·Kidney International ·Erwin Schleicher, Cora Weigert	204
16	Identification of N2-(1-carboxymethyl)guanine (CMG) as a guanine advanced glycation end product 1998 ·Bioorganic & Medicinal Chemistry Letters ·Yousef Al‐Abed, Erwin Schleicher, Wolfgang Voelter, H.M. Liebich, Andrew T. Papoulis, Richard Bucala	7
17	Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging. breakdown → 1997 ·Journal of Clinical Investigation ·Erwin Schleicher, Ernst Wagner, Michael Nerlich	603
18	High glucose-induced TGF-beta 1 regulates mesangial production of heparan sulfate proteoglycan 1996 ·American Journal of Physiology-Renal Physiology ·(unknown), Ulrich Sauer, (unknown), Erwin Schleicher	52
19	Atherogenic levels of low density lipoprotein alter the permeability and composition of the endothelial barrier 1994 ·Atherosclerosis ·(unknown), Klaus-Dieter Gerbitz, Bernhard Olgemöller, Erwin Schleicher	48
20	Comparison of various basement membrane components in benign and malignant peripheral nerve tumours 1992 ·Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·Sibylle Haraida, Michael Nerlich, K. Bise, Irmgard Wiest, Erwin Schleicher	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact